# SFXN4

## Overview
SFXN4 is a gene that encodes the protein sideroflexin 4, a member of the sideroflexin family, which is characterized by its role as a mitochondrial transmembrane protein. Sideroflexin 4 is integral to the inner mitochondrial membrane and is involved in the biogenesis of iron-sulfur (Fe-S) clusters, which are essential for mitochondrial respiration and iron metabolism (Paul2019Sideroflexin; Attwood2021Characterization). The protein's function is critical for maintaining cellular iron homeostasis and energy production, as it facilitates the redistribution of iron from the cytosol to mitochondria and influences heme synthesis (Paul2019Sideroflexin). Mutations or deficiencies in SFXN4 can lead to significant mitochondrial disorders, including complex I deficiency and macrocytic anemia, highlighting its importance in normal cellular function and health (HildickSmith2013Macrocytic; Sofou2019Prenatal).

## Structure
Sideroflexin 4 (SFXN4) is a mitochondrial membrane protein that is part of the sideroflexin family, characterized by having five transmembrane domains. These domains are predicted to form alpha-helices, which are typical of the secondary structure of transmembrane proteins (Paul2019Sideroflexin; Li2010Developmental). The primary structure of SFXN4 includes conserved HPDT and asparagine-rich domains, although the exact functions of these domains remain unclear (Paul2019Sideroflexin). 

SFXN4 is involved in iron-sulfur cluster biogenesis, which is crucial for mitochondrial respiration and iron metabolism (Paul2019Sideroflexin). The protein does not have a canonical mitochondrial targeting sequence, which is unusual for mitochondrial proteins, suggesting a unique mechanism of mitochondrial localization (Paul2019Sideroflexin). 

While specific details about the tertiary and quaternary structures of SFXN4 are not provided, the protein's role in mitochondrial function and its involvement in diseases related to mitochondrial iron-sulfur cluster biogenesis suggest a complex structural organization that supports its functional activities (Paul2019Sideroflexin; Sofou2019Prenatal). Post-translational modifications such as phosphorylation may occur, although specific modifications are not detailed in the available literature.

## Function
Sideroflexin 4 (SFXN4) is a nuclear-encoded mitochondrial protein that plays a critical role in several cellular processes, particularly in mitochondrial function and iron metabolism. SFXN4 is localized to the inner mitochondrial membrane and is involved in the biogenesis of iron-sulfur (Fe-S) clusters, which are essential for the function of various mitochondrial and cytosolic proteins (Paul2019Sideroflexin; Attwood2021Characterization). These clusters are crucial for electron transfer proteins and cellular iron homeostasis, impacting mitochondrial respiration and energy production (Paul2019Sideroflexin).

SFXN4 also plays a significant role in maintaining iron homeostasis by redistributing iron from the cytosol to mitochondria, affecting the cytosolic aconitase-IRP1 switch, and influencing heme synthesis by modulating levels of ferrochelatase and ALAS2 (Paul2019Sideroflexin). The protein's activity is essential for mitochondrial respiration, as its knockout leads to impaired Fe-S cluster formation, reduced levels of respiratory chain complexes, and a metabolic shift from oxidative phosphorylation to glycolysis (Paul2019Sideroflexin).

Mutations or deficiencies in SFXN4 can lead to severe mitochondrial disorders, including complex I deficiency, macrocytic anemia, and optic nerve hypoplasia, underscoring its importance in normal mitochondrial function and overall cellular health (Attwood2021Characterization; HildickSmith2013Macrocytic).

## Clinical Significance
Mutations in the SFXN4 gene are associated with several mitochondrial diseases, particularly those involving mitochondrial dysfunction and hematopoietic abnormalities. These mutations can lead to macrocytic anemia and mitochondriopathy, as demonstrated in studies involving individuals with distinct mutations in SFXN4. For instance, a homozygous single-nucleotide deletion in SFXN4 resulted in a severe loss-of-function phenotype, while compound heterozygous mutations led to a milder clinical course (HildickSmith2013Macrocytic). 

SFXN4 mutations have also been linked to prenatal onset of mitochondrial disease, characterized by complex I deficiency, macrocytic anemia, and optic nerve hypoplasia. Patients with these mutations often exhibit severe visual impairment, intellectual disability, and developmental delays (Sofou2019Prenatal). 

The gene plays a crucial role in iron metabolism and mitochondrial respiration. Knockout studies have shown that SFXN4 deficiency leads to impaired Fe-S cluster biogenesis, mitochondrial iron overload, and decreased hemoglobin synthesis, contributing to anemia and altered metabolic pathways (Paul2019Sideroflexin). These findings underscore the clinical significance of SFXN4 in maintaining mitochondrial function and iron homeostasis.

## Interactions
Sideroflexin 4 (SFXN4) is involved in several interactions crucial for mitochondrial function. It plays a significant role in the biogenesis of iron-sulfur (Fe-S) clusters, which are essential for the activity of various mitochondrial and cytosolic proteins. SFXN4 knockout results in decreased levels of Fe-S cluster-containing proteins, such as SDHB, ACO2, PPAT, and POLD1, indicating its involvement in the stability and function of these proteins (Paul2019Sideroflexin). 

SFXN4 may interact with frataxin or other proteins like aconitase or the ISCU-NFS1 complex to facilitate Fe-S cluster maturation, although direct interactions have not been conclusively demonstrated (Tifoun2021Insights). The protein is also implicated in mitochondrial respiration, as its knockout leads to reduced levels of respiratory complexes I-IV, which contain heme and/or Fe-S clusters (Paul2019Sideroflexin). 

In the context of cancer, SFXN4 interacts with proteins involved in mitochondrial function and cancer progression, such as CISD2, TSFM, and OPA3, as identified through bioinformatics analyses (Du2023Comprehensive). These interactions suggest a role for SFXN4 in maintaining mitochondrial integrity and function, impacting cellular metabolism and disease progression.


## References


[1. (Li2010Developmental) Xiaojing Li, Dandan Han, Richard Kin Ting Kam, Xiaogang Guo, Miao Chen, Yong Yang, Hui Zhao, and Yonglong Chen. Developmental expression of sideroflexin family genes in xenopus embryos. Developmental Dynamics, 239(10):2742–2747, August 2010. URL: http://dx.doi.org/10.1002/dvdy.22401, doi:10.1002/dvdy.22401. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.22401)

[2. (Attwood2021Characterization) Misty M. Attwood and Helgi B. Schiöth. Characterization of five transmembrane proteins: with focus on the tweety, sideroflexin, and yip1 domain families. Frontiers in Cell and Developmental Biology, July 2021. URL: http://dx.doi.org/10.3389/fcell.2021.708754, doi:10.3389/fcell.2021.708754. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.708754)

[3. (Tifoun2021Insights) Nesrine Tifoun, José M. De las Heras, Arnaud Guillaume, Sylvina Bouleau, Bernard Mignotte, and Nathalie Le Floch. Insights into the roles of the sideroflexins/slc56 family in iron homeostasis and iron-sulfur biogenesis. Biomedicines, 9(2):103, January 2021. URL: http://dx.doi.org/10.3390/biomedicines9020103, doi:10.3390/biomedicines9020103. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines9020103)

[4. (HildickSmith2013Macrocytic) Gordon J. Hildick-Smith, Jeffrey D. Cooney, Caterina Garone, Laura S. Kremer, Tobias B. Haack, Jonathan N. Thon, Non Miyata, Daniel S. Lieber, Sarah E. Calvo, H. Orhan Akman, Yvette Y. Yien, Nicholas C. Huston, Diana S. Branco, Dhvanit I. Shah, Matthew L. Freedman, Carla M. Koehler, Joseph E. Italiano, Andreas Merkenschlager, Skadi Beblo, Tim M. Strom, Thomas Meitinger, Peter Freisinger, M. Alice Donati, Holger Prokisch, Vamsi K. Mootha, Salvatore DiMauro, and Barry H. Paw. Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. The American Journal of Human Genetics, 93(5):906–914, November 2013. URL: http://dx.doi.org/10.1016/j.ajhg.2013.09.011, doi:10.1016/j.ajhg.2013.09.011. This article has 54 citations.](https://doi.org/10.1016/j.ajhg.2013.09.011)

[5. (Du2023Comprehensive) Zhipeng Du, Zhongchao Zhang, Xu Han, Huaping Xie, Wei Yan, Dean Tian, Mei Liu, and Caijun Rao. Comprehensive analysis of sideroflexin 4 in hepatocellular carcinoma by bioinformatics and experiments. International Journal of Medical Sciences, 20(10):1300–1315, 2023. URL: http://dx.doi.org/10.7150/ijms.86990, doi:10.7150/ijms.86990. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijms.86990)

[6. (Paul2019Sideroflexin) Bibbin T. Paul, Lia Tesfay, C. R. Winkler, Frank M. Torti, and Suzy V. Torti. Sideroflexin 4 affects fe-s cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes. Scientific Reports, December 2019. URL: http://dx.doi.org/10.1038/s41598-019-55907-z, doi:10.1038/s41598-019-55907-z. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-55907-z)

[7. (Sofou2019Prenatal) Kalliopi Sofou, Carola Hedberg-Oldfors, Gittan Kollberg, Christer Thomsen, Åsa Wiksell, Anders Oldfors, and Már Tulinius. Prenatal onset of mitochondrial disease is associated with sideroflexin 4 deficiency. Mitochondrion, 47:76–81, July 2019. URL: http://dx.doi.org/10.1016/j.mito.2019.04.012, doi:10.1016/j.mito.2019.04.012. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mito.2019.04.012)